Recombinant measles AIK-C vaccine strain expressing heterologous virus antigens

详细信息    查看全文

• 作者：Tetsuo Nakayama ; ^{tetsuo-n@lisci.kitasato-u.ac.jp" class="auth_mail" title="E-mail the corresponding author} ; Akihito Sawada ; Yoshiaki Yamaji ; Takashi Ito
• 关键词：AIK-C measles vaccine ; Reverse genetics ; Recombinant virus ; Respiratory syncytial virus
• 刊名：Vaccine
• 出版年：2016
• 出版时间：4 January 2016
• 年：2016
• 卷：34
• 期：2
• 页码：292-295
• 全文大小：826 K

文摘

Further attenuated measles vaccines were developed more than 50 years ago and have been used throughout the world. Recombinant measles vaccine candidates have been developed and express several heterologous virus protective antigens. Immunogenicity and protective actions were confirmed using experimental animals: transgenic mice, cotton rats, and primates. The recent development of measles vaccine-based vectored vaccine candidates has been reviewed and some information on recombinant measles vaccines expressing respiratory syncytial virus proteins has been shown and discussed.